Difference between revisions of "Team:Queens Canada/Parts"
Line 93: | Line 93: | ||
<img src="https://static.igem.org/mediawiki/2015/d/dc/Qqq_QGEM_BBa_K1831000.png" style="display: block; margin-left: auto; margin-right: auto;"/> | <img src="https://static.igem.org/mediawiki/2015/d/dc/Qqq_QGEM_BBa_K1831000.png" style="display: block; margin-left: auto; margin-right: auto;"/> | ||
<p><strong>What:</strong> Starting from the NpuDnaE intein RFC [105] circularization construct BioBrick from Team Heidelberg 2014 (<a href="http://parts.igem.org/Part:BBa_K1362000">BBa_K1362000</a>) we developed a computationally-optimized linker sequence to circularize a Type III antifreeze protein. Our linker consists of the tripeptide GAA, which in addition to the extein scar CWE/RGK, links the N and C termini of a the Type III AFP (PDB file: 1AME) without straining the core protein structure or distorting the residues critical for ice-binding. Our BioBrick also added a constitutive T7 promoter (Part BBa_I14018) allowing expression of your circular protein without any additional sub-cloning steps.</p> | <p><strong>What:</strong> Starting from the NpuDnaE intein RFC [105] circularization construct BioBrick from Team Heidelberg 2014 (<a href="http://parts.igem.org/Part:BBa_K1362000">BBa_K1362000</a>) we developed a computationally-optimized linker sequence to circularize a Type III antifreeze protein. Our linker consists of the tripeptide GAA, which in addition to the extein scar CWE/RGK, links the N and C termini of a the Type III AFP (PDB file: 1AME) without straining the core protein structure or distorting the residues critical for ice-binding. Our BioBrick also added a constitutive T7 promoter (Part BBa_I14018) allowing expression of your circular protein without any additional sub-cloning steps.</p> | ||
− | <p><strong>Why:</strong> Type III AFPs have a variety of potential applications in the oil and gas, food, and health industries, however these industries often use processes involving extreme temperatures, pH levels, and salt concentrations. Type III AFP is a particularly fragile protein as it denatures at | + | <p><strong>Why:</strong> Type III AFPs have a variety of potential applications in the oil and gas, food, and health industries, however these industries often use processes involving extreme temperatures, pH levels, and salt concentrations. Type III AFP is a particularly fragile protein as it denatures at 37<sup>o</sup>C. Circularizing the protein using our BioBrick affords greater stability at a wider variety of experimental conditions</p> |
<br> | <br> | ||
<h2>BBa_K1831001</h2> | <h2>BBa_K1831001</h2> |
Latest revision as of 02:46, 17 September 2015